Hitting the Target with IL-23 Inhibitors in Psoriatic Arthritis

Hitting the Target with IL-23 Inhibitors in Psoriatic Arthritis is organized by CME Outfitters, LLC.

Premiere Date: Wednesday, November 4, 2020
Credit Expiration Date: Thursday, November 4, 2021

This activity offers CE credit for:
• Pharmacists (ACPE)
• Nurses (CNE)
• Pharmacists (ACPE)
• ABIM (MOC)
• Other

Statement of Need:
Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal disease with a significant influence on the quality of life and functional ability. Despite the data showing the overall result of PsA, delays in diagnosis are common, which can lead to long-term joint damage and functional disability.

In this CME Outfitters Live and OnDemand activity, expert faculty will concentrate on assessment, treatment, and management strategies to accommodate patients with the best treatment aligned with emerging evidence and expert recommendations.

Course Objectives:
At the end of this CE activity, participants should be able to:
• Reduce diagnostic obstacles through better identification of signs and symptoms of PsA.
• Employ key clinical efficacy and safety data for IL-23 inhibitors to treatment decisions in patients with PsA.
• Cooperate with patients to optimize treatment regimens across the health continuum.

The following learning objectives pertain only to those requesting CNE or CPE credit:
• Explain ways to minimize diagnostic delays through better identification of signs and symptoms of PsA.
• Recognize key clinical efficacy and safety data for IL-23 inhibitors for treatment decisions in patients with PsA.
• Review how to collaborate with patients to optimize treatment regimens across the health care continuum.